No Data
Is Evotec SE (EVO) the Best German Stock to Buy Now?
Evotec Plunges Amid Report It's Against Halozyme Therapeutics Takeover
Halozyme Says EUR2 Billion Takeover of Evotech Would Create Leader in Drug Discovery
Deutsche Bank Remains a Sell on Evotec (0IRF)
Halozyme Therapeutics (HALO.US) plans to acquire Evotech (EVO.US) for 2.1 billion dollars in cash.
Halozyme Therapeutics financed the acquisition of German company Evotec for 2 billion euros (equivalent to 2.1 billion dollars) in cash.
Key Deals This Week: Exxon, Unilever, Cardinal Health, Charter Communications and More
No Data
No Data